1. Home
  2. DCTH vs PRCH Comparison

DCTH vs PRCH Comparison

Compare DCTH & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • PRCH
  • Stock Information
  • Founded
  • DCTH 1988
  • PRCH 2012
  • Country
  • DCTH United States
  • PRCH United States
  • Employees
  • DCTH N/A
  • PRCH N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • PRCH Computer Software: Prepackaged Software
  • Sector
  • DCTH Health Care
  • PRCH Technology
  • Exchange
  • DCTH Nasdaq
  • PRCH Nasdaq
  • Market Cap
  • DCTH 352.0M
  • PRCH 462.6M
  • IPO Year
  • DCTH N/A
  • PRCH N/A
  • Fundamental
  • Price
  • DCTH $11.34
  • PRCH $5.66
  • Analyst Decision
  • DCTH Strong Buy
  • PRCH Buy
  • Analyst Count
  • DCTH 4
  • PRCH 8
  • Target Price
  • DCTH $21.50
  • PRCH $5.34
  • AVG Volume (30 Days)
  • DCTH 346.0K
  • PRCH 2.9M
  • Earning Date
  • DCTH 11-08-2024
  • PRCH 11-07-2024
  • Dividend Yield
  • DCTH N/A
  • PRCH N/A
  • EPS Growth
  • DCTH N/A
  • PRCH N/A
  • EPS
  • DCTH N/A
  • PRCH N/A
  • Revenue
  • DCTH $22,644,000.00
  • PRCH $452,099,000.00
  • Revenue This Year
  • DCTH $1,605.13
  • PRCH $6.31
  • Revenue Next Year
  • DCTH $111.67
  • PRCH N/A
  • P/E Ratio
  • DCTH N/A
  • PRCH N/A
  • Revenue Growth
  • DCTH 945.91
  • PRCH 19.04
  • 52 Week Low
  • DCTH $3.70
  • PRCH $1.05
  • 52 Week High
  • DCTH $13.30
  • PRCH $6.04
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 51.29
  • PRCH 62.85
  • Support Level
  • DCTH $10.75
  • PRCH $4.32
  • Resistance Level
  • DCTH $13.30
  • PRCH $6.04
  • Average True Range (ATR)
  • DCTH 0.70
  • PRCH 0.64
  • MACD
  • DCTH -0.12
  • PRCH -0.08
  • Stochastic Oscillator
  • DCTH 23.13
  • PRCH 78.13

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions.

Share on Social Networks: